Skip to content
★ Sign in to follow
TM

Thadd M. Vargas

Executive
Depomed Inc
Total declarations
37
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€4.9M

Latest filing published 15 Jun 2017 for DEPOMED INC, €186k.

Filing timeline

BuySale
Thadd M. Vargas

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

Thadd M. Vargas: trading record in brief

Thadd M. Vargas discloses dealings in Depomed Inc to SEC (Form 4). In total, 37 filings cover trades dated from 8 September 2011 to 13 June 2017.

The open-market record consists of 14 sales worth €4.9M, with no purchase. Outside the open market, there are 4 share grants and 19 option exercises. So far in 2017, the count stands at no purchases and 4 sales.

The newest entry dates from 15 June 2017: an open-market sale of €186k, in Depomed Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Thadd M. Vargas

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations37 total
  • ▼
    SVP, Business DevelopmentExecutivesDepomed Inc
    208,592 USD11SEC
    21,751 shares@ US$9.593.6% of flowCommon StockSEC:0001179110-17-009109:0
  • ▼
    SVP, Business DevelopmentExecutivesDepomed Inc
    190,234 USD11SEC
    19,816 shares@ US$9.603.3% of flowCommon StockSEC:0001179110-17-009109:1
  • ◇
    SVP, Business DevelopmentExecutivesDepomed Inc
    137,558 USD11SEC
    19,320 shares@ US$7.122.4% of flowCommon StockSEC:0001179110-17-009109:2
  • ◇
    SVP, Business DevelopmentExecutivesDepomed Inc
    273,600 USD11SEC
    45,000 shares@ US$6.084.8% of flowCommon StockSEC:0001179110-17-009109:3
  • ◇
    SVP, Business DevelopmentExecutivesDepomed Inc
    262,730 USD11SEC
    43,000 shares@ US$6.114.6% of flowCommon StockSEC:0001179110-17-009109:4
  • ◇
    SVP, Business DevelopmentExecutivesDepomed Inc
    362,195 USD12SEC
    53,500 shares@ US$6.776.3% of flowCommon StockSEC:0001179110-17-009109:5
  • ▼
    SVP, Business DevelopmentExecutivesDepomed Inc
    2M USD14SEC
    160,820 shares@ US$9.5326.7% of flowCommon StockSEC:0001179110-17-009109:6
  • ▼
    Senior VP, BDExecutivesDepomed Inc
    601,500 USD24SEC
    50,000 shares@ US$12.0310.8% of flowCommon StockSEC:0001179110-17-007220:0
  • ◆
    Senior VP, BDExecutivesDepomed Inc
    11,797 USD11SEC
    940 shares@ US$12.550.2% of flowCommon StockSEC:0001179110-17-005718:0
  • ◆
    Senior VP, BDExecutivesDepomed Inc
    186,502 USD11SEC
    10,054 shares@ US$18.553.4% of flowCommon StockSEC:0001179110-16-032492:0
  • ▼
    Senior VP, BDExecutivesDepomed Inc
    281,250 USD11SEC
    11,250 shares@ US$25.004.9% of flowCommon StockSEC:0001179110-16-029940:0
  • ▼
    Senior VP, BDExecutivesDepomed Inc
    549,987 USD24SEC
    26,290 shares@ US$20.929.6% of flowCommon StockSEC:0001179110-16-028585:0
  • ▼
    Senior VP, BDExecutivesDepomed Inc
    300,000 USD24SEC
    15,000 shares@ US$20.005.2% of flowCommon StockSEC:0001179110-16-025503:0
  • ▼
    Senior VP, BDExecutivesDepomed Inc
    264,600 USD23SEC
    15,000 shares@ US$17.644.6% of flowComon StockSEC:0001179110-16-024258:0
  • ◆
    Senior VP, BDExecutivesDepomed Inc
    13,517 USD11SEC
    940 shares@ US$14.380.2% of flowCommon StockSEC:0001179110-16-022840:0
  • ▼
    Senior VP, BDExecutivesDepomed Inc
    368,000 USD12SEC
    23,000 shares@ US$16.006.4% of flowComon StockSEC:0001179110-16-021586:0
  • ▼
    SVP, Business DevelopmentExecutivesDepomed Inc
    151,800 USD11SEC
    10,000 shares@ US$15.182.7% of flowCommon StockSEC:0001179110-16-021107:0
  • ◇
    SVP, Business DevelopmentExecutivesDepomed Inc
    0SEC
    18,180 sharesCommon StockSEC:0001179110-16-017698:0
  • ◆
    Senior VP, BDExecutivesDepomed Inc
    265,240 USD0SEC
    13,960 shares@ US$19.00Common StockSEC:0001179110-15-015764:0
  • ▼
    Senior VP, BDExecutivesDepomed Inc
    103,500 USD0SEC
    5,000 shares@ US$20.70Comon StockSEC:0001179110-15-009833:0
  • ◇
    Senior VP, BDExecutivesDepomed Inc
    330,225 USD0SEC
    52,500 shares@ US$6.29Common StockSEC:0001179110-15-006186:0
  • ◇
    Senior VP, BDExecutivesDepomed Inc
    6,750 USD0SEC
    1,875 shares@ US$3.60Common StockSEC:0001179110-15-006186:1
  • ◇
    Senior VP, BDExecutivesDepomed Inc
    1,035 USD0SEC
    335 shares@ US$3.09Common StockSEC:0001179110-15-006186:2
  • ◇
    Senior VP, BDExecutivesDepomed Inc
    95,570 USD0SEC
    19,000 shares@ US$5.03Common StockSEC:0001179110-15-001154:0
  • ▼
    Senior VP, BDExecutivesDepomed Inc
    130,715 USD0SEC
    8,247 shares@ US$15.85Common StockSEC:0001179110-14-017514:0

25 of 37 declarations